Voiant Acquires Voxeleron

August 2, 2025

Voiant has acquired Voxeleron, an AI-driven ophthalmic image analysis company, to integrate advanced AI/ML imaging capabilities into its clinical trial imaging platform. The deal combines Voiant’s clinical trial imaging expertise with Voxeleron’s cloud-based image analysis tools to accelerate biomarker development, improve data accuracy, and enhance ophthalmology-focused clinical research services.

Buyers
Voiant
Targets
Voxeleron
Location
Texas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.